FDA Inspection 922889 — Tianjin Central Pharmaceutical Co., Ltd.

Tianjin Central Pharmaceutical Co., Ltd. — FEI 3003780972

The FDA completed an inspection of Tianjin Central Pharmaceutical Co., Ltd. on Mar 20, 2015 in Tianjin. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 20, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Tianjin (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.